Fluoxetine hydrochloride

盐酸氟西汀

Report date: 2026/05/21 20:00:22
NME

Base Information

Drug NameFluoxetine hydrochloride
Drug Alias NameZactin聚立能奥麦伦Reneuronfluoxetina +[24] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionSerotonin transporter inhibitors
TargetsSerotonin transporter
Therapy Area/IndicationsHemorrhagic StrokeIschemic StrokeStress Disorders, Post-Traumatic +[42] 
Global Approved IndicationsDepressive Disorder, Treatment-ResistantDepressive Disorder, MajorBulimia Nervosa +[7] 
Approved Indications in ChinaBulimia NervosaObsessive-Compulsive DisorderDepression
Original Approved Country/TerritoryUnited States
Original Approved Date1987/12/29
Country/TerritoryCanadaUnited StatesSweden +[9] 
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesEli Lilly And Company
China Registration ClassN/A

Develop Information

Active CompaniesEli Lilly And CompanyDuke UniversityUniversity Of Maryland, Baltimore +[10] 
Inactive CompaniesChengdu University Of TcmSandozUniversity of Texas Southwestern Medical Center +[31] 
Active IndicationsHemorrhagic StrokeDepressive Disorder, Treatment-ResistantDepressive Disorder, Major +[20] 
Inactive IndicationsIschemic StrokeStress Disorders, Post-TraumaticHypochondriasis +[22] 

Other Information

ATC CodeN06AB03
Related LinksWikipediaDrugBankKEGG